We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Applied BioCode, Diatherix Ink Partnership

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Diatherix Laboratories will utilize Applied BioCode's Barcoded Magnetic Beads and BioCode detection systems in conjunction with their proprietary TEM-PCR™ technology to develop highly sensitive multiplex molecular diagnostic infectious disease panels for their laboratory customers. 

"We are very pleased to partner with Diatherix Laboratories in this important area of the market," said Winston Ho, President of Applied BioCode. "Our Barcoded Magnetic Beads combined with the Diatherix TEM-PCR™ technology will provide an elegant solution for multiplexing of molecular diagnostic infectious disease tests. We embrace their ability to quickly identify co-infections and link diagnostics testing to the right therapeutic to significantly improve patient outcomes and reduce overall healthcare costs." 

"We are pleased to partner with Applied BioCode for their Barcoded Magnetic Bead technology," said Dennis Grimaud, CEO of Diatherix Laboratories. "Their Barcoded Magnetic Bead technology will allow us to reduce the development timeframe to bring new multiplex test panels to market and enhance the sensitivity of our molecular diagnostic panels. We look forward to a long and successful partnership with Applied BioCode."